Furthermore, the increases in collagen density, trabecular spaces, Young’s modulus, and ultimate strain parameters and the reduced MMP-9 gene expression in the T1DMS group compared to the T1DM group and the similarity of these values to the control group suggest that zinc supplementation protects against organic matrix degradation and bone loss. The gene discussed is MMP9; the disease is type 1 diabetes mellitus.